The method of any one of embodiments 49-56, wherein the composition comprises between about 0.01% to about 10% by weight of the silicon dioxide, about 0.01% to about 7% by weight of the silicon dioxide, about 0.01% to about 5% by weight of the silicon dioxide, about 0.01% to about 3% by weight of the silicon dioxide, about 0.01% to about 2% by weight of the silicon dioxide, or about 0.01% to about 1% by weight of the silicon dioxide
Hi serendipity16, Thank-you for your reply
The purpose of this study was to develop a PLGA-specific melting point depression method that did not require a cryo-milling operation
This gradual titration approach is consistent with the prescribing philosophy applied to other incretin-based therapies in the UK, where slow escalation is used to improve tolerability and encourage long-term adherence
As a scientist that spent over a decade researching inflammation and immunology, I just knew that this technology was clever, elegant and immensely exciting
